Using the levels of the three genes (HIST2H2AA3, LUZP6 and HLA-DRA) in exosomes as a signature, we obtained a high sensitivity and specificity (accuracy) in distinguishing patients with pancreatic cancer from healthy controls and from those with chronic pancreatitis in an independent study. Here, HLA-DRA is linked to pancreatic neoplasm.